Search

Finance

Deep Dive with DFC’s Nafisa Jiwani | Development Finance & Opportunity in Global Health

The Alliance invites members to join us on Thursday, February 12, 2026 at 8 AM PT for a virtual deep dive session with Nafisa Jiwani, Associate Vice President of Health Initiatives at the U.S. Development Finance Corporation (DFC). This timely session on development financing and opportunities in global health will help participants understand how DFC capital works in practice, what types of health projects and business models are most competitive, which organizations might be eligible, and how to position opportunities to align with DFC’s investment priorities and processes.

Join Us: Deep Dive with DFC’s Nafisa Jiwani | Development Finance and Opportunity in Global Health

The Alliance invites members to join us on Thursday, February 12, 2026 at 8 AM PT for a virtual deep dive session with Nafisa Jiwani, Associate Vice President of Health Initiatives at the U.S. Development Finance Corporation (DFC). This timely session on development financing and opportunity in global health will help participants understand how DFC capital works in practice, what types of health projects and business models are most competitive, which organizations might be eligible, and how to position opportunities to align with DFC’s investment priorities and processes.

JPM 2026 | From Products to Patients: Capturing Value in Asia and Africa’s Growth Markets

For the third consecutive year, the Alliance convened a panel at the 2026 J.P. Morgan Healthcare Conference (JPM) in San Francisco, followed by an Alliance side meeting held at Accenture’s San Francisco Innovation Hub. This year’s panel brought together leaders from Gilead Sciences, U.S. Development Finance Corporation (DFC), Nivi, Inc., reach52, and Accenture to explore how pharmaceutical partnerships, development finance, and patient platforms are creating investable infrastructure in high-growth markets across Asia and Africa. The panel underscored that the most promising long-term opportunities in emerging markets lie not just in individual products, but in the systems and partnerships that connect them to patients.

JPM 2026 | From Products to Patients: Capturing Value in Asia’s Growth Markets

Alliance Events, In-person

At the J.P. Morgan Healthcare Conference 2026, the Alliance will convene another strategic panel, From Products to Patients: Capturing Value in Asia’s Growth Markets, bringing together Gilead Sciences’ SVP of Emerging Markets, the head of U.S. DFC’s global health investments, and the CEOs of reach52 and Nivi, Inc. to explore how pharmaceutical partnerships, development finance, and patient platforms are creating investable infrastructure in high-growth markets across Asia. A post-JPM panel reception will follow, offering a continuation of the conversation and networking opportunities from 4:30-6:30pm PT.

Center of Excellence in Maternal, Child, & Adolescent Health Secures $1.8M Five-Year Federal Funding

UC Berkeley Read More

Big Aid is Over – What’s Next for Doers and Donors?

In-person

Co-hosted by the Network of Engaged International Donors (NEID Global) and Dalberg, join Kevin Starr, CEO of Mulago Foundation, and Ina Breuer, NEID Global Executive Director, on October 7 as they discuss strategies for scaling sustainable interventions in the post-‘Big Aid’ era.